Hospital Mãe de Deus

Institution (Healthcare)

Homepage ROR

Also Known As

Hospital Mãe de Deus · Acronym: HMD

1.1K

Publications

27K

Citations

Authors

261

Concepts

About

Hospital Mãe de Deus is a healthcare institution in Porto Alegre, Brazil known for medicine, health sciences, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	123	9.8K
2	Health Sciences	17	46	3K
3	Public Health	14	29	4.2K
4	Engineering	2	2	34
5	Education	1	4	76

Hospital Mãe de Deus

1.1K

Publications

27K

Citations

Page 1

	Year	Citations
Decisions in Changing Conditions: The Urgency-Gating Model Paul Cisek, Geneviève Aude Puskas, Stephany El-Murr Journal of Neuroscience	2009	547
Challenges to effective cancer control in China, India, and Russia Paul E. Goss, Kathrin Strasser‐Weippl, Brittany Bychkovsky, The Lancet Oncology MedicineGlobal HealthCancer ManagementCancer PreventionBreast Cancer	2014	497
Planning cancer control in Latin America and the Caribbean Paul E. Goss, Brittany Lee, Tanja Badovinac-Črnjević, The Lancet Oncology Preventive MedicineMedicineGlobal HealthEpidemiology Of CancerCancer Prevention	2013	496
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial Frits van Rhee, Raymond Wong, Nikhil C. Munshi, The Lancet Oncology MedicineMulticentric CastlemanScleroderma	2014	420
An evaluation of gender, obesity, age and diabetes mellitus as risk factors for carpal tunnel syndrome Jéfferson Becker, Daniel Bocchese Nora, Irênio Gomes, Clinical Neurophysiology ObesityBody CompositionDiabetes EpidemiologyDiabetesCarpal Tunnel Syndrome	2002	388
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael, The Lancet Hematological MalignancyRelapsed Multiple MyelomaMedicineRandomised Phase 3Immunology	2021	366
Conventional rotator cuff repair complemented by the aid of mononuclear autologous stem cells João Luiz Ellera Gomes, Ricardo Canquerini da Silva, Lúcia M. R. Silla, Knee Surgery Sports Traumatology Arthroscopy	2011	258
Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis James Larkin, Bartosz Chmielowski, Christopher D. Lao, The Oncologist	2017	257
Daratumumab plus bortezomib and dexamethasone <i>versus</i> bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR Andrew Spencer, Suzanne Lentzsch, Katja Weisel, Haematologica	2018	254
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial Mikhail Kosiborod, Russell Esterline, Remo H.M. Furtado, The Lancet Diabetes & Endocrinology Cardiovascular DiseaseCardiometabolic RiskCardiovascular PharmacologyRiskCardiometabolic Risk Factors	2021	235

Page 1